The Codexis-backed SynBio Innovation Accelerator will target early-stage biotech developers and has made Arzeda its first portfolio company.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The $22.5m drug discovery fund is backed by University of Utah's Huntsman Cancer Institute and College of Pharmacy.

The proteomics technology provider, backed by Nan Fung, iCarbonX, Novartis, Otsuka and Quest Diagnostics, has now secured $485m in total.

The ophthalmic biotherapeutics developer has completed a series A round co-led by Eli Lilly unit Lilly Asia Ventures nine months after it was founded.

Summation Health Ventures returned for a series C round that lifted the healthcare communication system provider's total funding to $45m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

M2P-Labs, a supplier of microbioreactors based on RWTH Aachen intellectual property, has agreed to an acquisition by Beckman Coulter Life Sciences.

Telus Pollinator Fund for Good is equipped with $76.5m to invest in developers of technology that can promote positive social and environmental impact.